Synbio Tech   Report issue

For profit
Founded: Kaohsiung Taiwan (2000)

Organization Overview

First Clinical Trial
2019
NCT04293666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

SYNBIO TECH INC. | SYNBIO TECH INC. Kaohsiung Taiwan

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 8